|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00932581 |
|
Date of registration:
|
01/07/2009 |
|
Primary sponsor: |
|
|
Public title:
|
Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties
Bravura |
|
Scientific title:
|
Investigation of the Psychometric Properties of the Bradykinesia Subscale When Administered Alone Versus as a Component of the Entire Motor Examination Section of the Unified Parkinson's Disease Rating Scale |
|
Date of first enrolment:
|
June 2009 |
|
Target sample size:
|
110 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00932581 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Philip Buck, PhD, MPH |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Teva Neuroscience, Inc. |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Male or Female at least 30 years of age
2. Willing to be assessed using the motor examination section of the UPDRS and the
SPES/SCOPA motor evaluation
3. Patients must be willing and able to give written informed consent prior to
performing an study procedures
4. Be in the "ON" State (only for patients who fluctuate between "ON" and "OFF" states)
Exclusion Criteria:
1. Absence of bradykinesia at the time of assessment
2. Hoehn and Yahr stage not available from patient's chart or not assessed between 3 and
180 days prior to clinic visit
3. Has received and experimental drug within the last thirty (30) days
Age minimum:
30 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Parkinson's Disease
|
|
Intervention(s)
|
|
Other: Bradykinesia subscale of UPDRS Motor Examination
|
|
Other: Bradykinesia UPDRS Motor Full Examination
|
|
Primary Outcome(s)
|
|
Scores on the UPDRS motor evaluation subscale are equivalent.
[Time Frame: 4 months]
|
|
Secondary Outcome(s)
|
|
Correlations between the UPDRS motor examination bradykinesis subscale and the remaining UPDRS motor examination items, Hoeh and Yahr stage, Schwab and England scale, and SPES/SCOPA motor evaluation.
[Time Frame: 4 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|